CellaVision AB (publ) (OTCMKTS:CLVSF) Sees Large Decline in Short Interest

CellaVision AB (publ) (OTCMKTS:CLVSF) was the target of a large drop in short interest in the month of March. As of March 31st, there was short interest totalling 1,500 shares, a drop of 6.3% from the March 15th total of 1,600 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is currently 15.0 days.

CellaVision AB (publ) Stock Performance

CellaVision AB (publ) stock opened at $20.36 on Thursday. CellaVision AB has a one year low of $20.36 and a one year high of $23.75. The business has a 50 day simple moving average of $20.54 and a 200 day simple moving average of $18.06.

CellaVision AB (publ) Company Profile

CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears.